NCT04053790View on ClinicalTrials.gov

Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)

PHASE4CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

January 29, 2023

Study Completion Date

January 29, 2023

Conditions
Irritable Bowel Syndrome With Diarrhea
Interventions
DRUG

lactobacillus LB

administration of different doses of Lactobacillus LB according to the treatment groups described previously

OTHER

placebo

a tablet of placebo every 12 hours given by mouth

Trial Locations (1)

06726

Hospital General de Mexico, Mexico City

All Listed Sponsors
lead

Hospital General de Mexico

OTHER_GOV

NCT04053790 - Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) | Biotech Hunter | Biotech Hunter